血浆miR-205在乙肝病毒相关肝脏疾病中的表达及其作为乙肝病毒所致肝细胞癌诊断标志物的价值 Differential Expression of Plasma miR-205 in HBV-Related Liver Diseases and Diagnostic Potential for HBV-Induced Hepatocellular Carcinoma
Zhang ZZ,Liu X,Wang DQ,et al.Hepatitis B virus and hepatocellular carcinoma at the miRNA level[J].World J Gastroenterol,2011,17(28):3 353-3 358.
[5]
Zhang T,Zhang J,Cui M,et al.Hepatitis B virus X protein inhibits tumor suppressor miR-205through inducing hypermethylation of miR-205promoter to enhance carcinogenesis[J].Neoplasia,2013,15(11):1 282-1 291.
[6]
Mitchell PS,Parkin RK,Kroh EM,et al.Circulating microRNAs as stable blood-based markers for cancer detection[J].Proc Natl Acad Sci USA,2008,105(30):10 513-10 518.
[7]
El-Serag HB.Epidemiology of viral hepatitis and hepatocellular carcinoma[J].Gastroenterology,2012,142(6):1 264-1 273.
[8]
Fernandez-Rodriguez CM,Gutierrez-Garcia ML.Prevention of hepatocellular carcinoma in patients with chronic hepatitis B[J].World J Gastrointest Pharmacol Ther,2014,5(3):175-182.
[9]
Tarocchi M,Polvani S,Marroncini G,et al.Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis[J].World J Gastroenterol,2014,20(33):11 630-11 640.
[10]
Qi P,Cheng SQ,Wang H,et al.Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection[J].PLoS One,2011,6(12):e28486.
[11]
Xu J,Wu C,Che X,et al.Circulating microRNAs,miR-21,miR-122,and miR-223,in patients with hepatocellular carcinoma or chronic hepatitis[J].Mol Carcinog,2011,50(2):136-142.
